Lipid peroxidation and antioxidants status in human malignant and non-malignant thyroid tumours

Human and Experimental Toxicology

Volumn 35, Issue 6, 2016, Pages 585-597

  Stanley, J A ^a,b   Neelamohan, R ^a   Suthagar, E ^a   Vengatesh, G ^a   Jayakumar, J ^c   Chandrasekaran, M ^c   Banu, S K ^b   Aruldhas, M M ^a  

^a UNIVERSITY OF MADRAS   (India)

^b TEXAS A AND M UNIVERSITY   (United States)

^c MADRAS MEDICAL COLLEGE   (India)

Author keywords

catalase; GPx; GSH; Hashimoto's thyroiditis; LPO; Oxidative stress; thyroid cancer; thyroid goitre

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; THYROID HORMONE; THYROTROPIN;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; FOLLICULAR THYROID ADENOMA; FOLLICULAR THYROID CARCINOMA; GOITER; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; INSULAR THYROID CARCINOMA; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MULTINODULAR GOITER; NODULAR GOITER; PRIORITY JOURNAL; THYROID CARCINOMA; THYROID GLAND TISSUE; THYROID MEDULLARY CARCINOMA; THYROID TUMOR; TOXIC GOITER; ADULT; BLOOD; CARCINOMA; METABOLISM; MIDDLE AGED; THYROID GLAND; THYROID NEOPLASMS;

ADULT; ANTIOXIDANTS; CARCINOMA; CATALASE; FEMALE; GLUTATHIONE PEROXIDASE; GOITER; HUMANS; LIPID PEROXIDATION; MIDDLE AGED; SUPEROXIDE DISMUTASE; THYROID GLAND; THYROID HORMONES; THYROID NEOPLASMS; THYROTROPIN;

EID: 84971225659     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327115597982     Document Type: Article

References (27)

1. Waris G, Ahsan H,. Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinogen 2006; 5: 14.
2. Valko M, Rhodes C, Moncol J, et al.Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem-biol Interact 2006; 160: 1-40.
3. Poli G, Leonarduzzi G, Biasi F, et al.Oxidative stress and cell signalling. Curr Med Chem 2004; 11: 1163-1182.
4. Denef J-F, Many M-C, Van den Hove M,. Iodine-induced thyroid inhibition and cell necrosis: two consequences of the same free-radical mediated mechanism? Mol Cell Endocrinol 1996; 121: 101-103.
5. 2-generating system modulates protein iodination and the activity of the pentose phosphate pathway in dog thyroid. Endocrinol 1991; 128: 779-785.
6. Boelaert K, Horacek J, Holder R, et al.Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metabol 2006; 91: 4295-4301.
7. Pajovic SB, Cavric G, Kasapovic J, et al.Activities of superoxide dismutase and catalase in cancerous and non-cancerous human kidney tissues. J Med Sci 2002; 2: 234-236.
8. Stanley JA, Aruldhas MM, Chandrasekaran M, et al.Androgen receptor expression in human thyroid cancer tissues: a potential mechanism underlying the gender bias in the incidence of thyroid cancers. J Steroid Biochem Mol Biol. 2012; 130: 105-124.
9. Devasagayam T, Tarachand U,. Decreased lipid peroxidation in the rat kidney during gestation. Biochem Biophys Res Commun 1987; 145: 134-138.
10. Marklund S, Marklund G,. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974; 47: 469-474.
11. Rotruck JT, Pope AL, Ganther HE, et al.Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973; 179: 588-590.
12. Boyne AF, Ellman GL,. A methodology for analysis of tissue sulfhydryl components. Anal Biochem 1972; 46: 639-653.
13. Sinha AK,. Colorimetric assay of catalase. Anal Biochem 1972; 47: 389-394.
14. Xing M,. Oxidative stress: a new risk factor for thyroid cancer. Endocr-Relat Canc 2012; 19: C7-C11.
15. Ademoglu E, Ozbey N, Erbil Y, et al.Determination of oxidative stress in thyroid tissue and plasma of patients with Graves' disease. Eur J Int Med 2006; 17: 545-550.
16. Senthil N, Manoharan S,. Lipid peroxidation and antioxidants status in patients with papillary thyroid carcinoma in India. Asia Pacific J Clin Nutrit 2004; 13: 391-395.
17. Vrndic OB, Radivojevic SD, Jovanovic MD, et al.Oxidative stress in patients with differentiated thyroid cancer: early effects of radioiodine therapy. Indian J Biochem Biophys 2014; 51: 223-229.
18. Durak I, Bayram F, Kavutcu M, et al.Impaired enzymatic antioxidant defense mechanism in cancerous human thyroid tissues. J Endocrinol Invest 1996; 19: 312-315.
19. Akinci M, Kosova F, Cetin B, et al.Oxidant/antioxidant balance in patients with thyroid cancer. Acta Cir Bras 2008; 23: 551-554.
20. Sadani GR, Nadkarni GD,. Role of tissue antioxidant defence in thyroid cancers. Canc Lett 1996; 109: 231-235.
21. Mano T, Shinohara R, Iwase K, et al.Changes in free radical scavengers and lipid peroxide in thyroid glands of various thyroid disorders. Horm Metab Res 1997; 29: 351-354.
22. Komosinska-Vassev K, Olczyk K, Kucharz EJ, et al.Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy. Clin Chim Acta 2000; 300: 107-117.
23. Fernandez V, Barrientos X, Kipreos K, et al.Superoxide radical generation, NADPH oxidase activity, and cytochrome P-450 content of rat liver microsomal fractions in an experimental hyperthyroid state: relation to lipid peroxidation. Endocrinol 1985; 117: 496-501.
24. Bjorkman U, Ekholm R,. Hydrogen peroxide degradation and glutathione peroxidase activity in cultures of thyroid cells. Mol Cell Endocrinol 1995; 111: 99-107.
25. Sugawara M, Kita T, Lee ED, et al.Deficiency of superoxide dismutase in endemic goiter tissue. J Clin Endocrinol Metab 1988; 67: 1156-1161.
26. Lassoued S, Mseddi M, Mnif F, et al.A comparative study of the oxidative profile in Graves' disease, Hashimoto's thyroiditis, and papillary thyroid cancer. Biol Trace Element Res 2010; 138: 107-115.
27. Rom-Boguslavskaia ES, Somova EV, Ovsiannikova TN, et al.Lipid peroxidation in thyroid tissue of people with diffuse toxic goiter. Ukr Biokhim Zh 1997; 69: 111-114.